25 Participants Needed

Mobile Health Intervention for Acute Kidney Injury in Children

EB
AW
Overseen ByAnna Williams
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Duke University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this study is to improve patient-centered care for acute kidney injury (AKI) in order to decrease the adverse health outcomes associated with this common condition.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

Is the Mobile Health Intervention for Acute Kidney Injury in Children safe?

The research articles do not provide specific safety data for the Mobile Health Intervention for Acute Kidney Injury in Children, but they discuss the use of digital applications and telemedicine for improving patient safety in related conditions, suggesting that such technologies can be safely used to enhance care.12345

How is the mobile health intervention for acute kidney injury in children different from other treatments?

This mobile health intervention is unique because it uses a digital app to support the management of acute kidney injury in children, offering personalized, condition-specific guidance for day-to-day care, which is not typically available with standard treatments.678910

Research Team

RG

Rasheed Gbadegesin, MD

Principal Investigator

Duke University

CJ

Clarissa J Diamantidis, MD

Principal Investigator

Duke University

Eligibility Criteria

This trial is for children aged 1 to 18 years who have been diagnosed with acute kidney injury (AKI) while in the hospital. It's not suitable for kids over 18 years and 11 months, those with cognitive impairments that prevent consent, non-English speakers, or those who are legally blind or deaf.

Inclusion Criteria

I was diagnosed with acute kidney injury while in the hospital.

Exclusion Criteria

I am legally blind or deaf.
Non-English speaking
I have difficulty understanding or making decisions due to cognitive issues.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Interviews

Interviews with families of patients diagnosed with AKI and providers to gather feedback on barriers and facilitators to pediatric AKI self-management

4 weeks

Tool Modification and Usability Testing

Modification of an existing educational tool based on interview feedback and usability testing

4 weeks

Pilot Testing

Pilot testing of the educational tool's impact on patient-centered care for pediatric AKI

4 weeks

Follow-up

Participants are monitored for safety and effectiveness after the intervention

4 weeks

Treatment Details

Interventions

  • Mobile Health Educational Tool
Trial Overview The study is testing a mobile health educational tool designed to improve care for children with AKI. The goal is to reduce negative health outcomes by providing patient-centered education through this technology.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Receiving Educational ToolExperimental Treatment1 Intervention
Patients in this arm will receive the educational tool after the pretest in addition to usual care.
Group II: Receiving Usual CareActive Control1 Intervention
Patients in this arm will receive usual care after the pretest.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Duke University

Lead Sponsor

Trials
2,495
Recruited
5,912,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Findings from Research

In a 1-year study involving 182 outpatients with advanced chronic kidney disease (CKD), the eKidneyCare app significantly reduced medication discrepancies compared to the MyMedRec app, indicating better medication management.
eKidneyCare not only lowered the total number of discrepancies but also reduced the severity of clinically relevant discrepancies, including those that could potentially cause serious harm, highlighting its effectiveness in improving medication safety for high-risk patients.
Digital Applications Targeting Medication Safety in Ambulatory High-Risk CKD Patients: Randomized Controlled Clinical Trial.Ong, SW., Jassal, SV., Porter, EC., et al.[2023]
Chronic kidney disease (CKD) patients face a high risk of adverse safety events due to factors like impaired kidney function and polypharmacy, which can lead to serious outcomes such as hospitalization and accelerated kidney function loss.
Telemedicine, particularly through interactive voice-response systems, offers a promising way for CKD patients to communicate safety-related issues to healthcare providers, although many patients face challenges in accessing these technologies.
Telemedicine to Promote Patient Safety: Use of Phone-Based Interactive Voice-Response System to Reduce Adverse Safety Events in Pre-dialysis CKD.Weiner, S., Fink, JC.[2022]
In a study involving 2,818 pediatric patients, the use of AKI risk alerts significantly increased the rate of serum creatinine (SCr) testing in intensive care settings, with 69% of at-risk patients tested compared to 60% in the control group.
However, the alerts did not lead to any differences in AKI incidence or severity in either intensive care or ward settings, indicating that while screening improved, it did not change the outcomes of AKI.
Acute kidney injury risk-based screening in pediatric inpatients: a pragmatic randomized trial.Van Driest, SL., Wang, L., McLemore, MF., et al.[2021]

References

Digital Applications Targeting Medication Safety in Ambulatory High-Risk CKD Patients: Randomized Controlled Clinical Trial. [2023]
Telemedicine to Promote Patient Safety: Use of Phone-Based Interactive Voice-Response System to Reduce Adverse Safety Events in Pre-dialysis CKD. [2022]
Acute kidney injury risk-based screening in pediatric inpatients: a pragmatic randomized trial. [2021]
Usability of a CKD educational website targeted to patients and their family members. [2021]
A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. [2021]
Children and young people's views on access to a web-based application to support personal management of long-term conditions: a qualitative study. [2022]
Systematic Evaluation of Smartphone Applications for the Medical Management of Nephrolithiasis. [2021]
The Development and Validation of a Mobile Application for Guidance for Management of Severe Diabetic Ketoacidosis. [2022]
Desirable Components for a Customized, Home-Based, Digital Care-Management App for Children and Young People With Long-Term, Chronic Conditions: A Qualitative Exploration. [2022]
Parental health literacy and progression of chronic kidney disease in children. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity